LONDON (Alliance News) - Hikma Pharmaceuticals PLC said Monday that a group of executives, including Chief Financial Officer Khalid Nabilsi, had received share awards that had vested.
The shares were acquired as follows:
PDMR | Type of Transaction | Exercised | Date | Price | Shares Disposed | Remaining Holding | ||
Bassam Kanaan
| Vesting of LTIP 2011 | 35,432 (0.02% ISC) | 24 March 2014 | £16.23 | Nil | 503,566 (0.25% ISC) | ||
Michael Raya
| Vesting of LTIP 2011 | 31,776 (0.02% ISC) | 24 March 2014 | £16.23 | Nil | 76,160 (0.04% ISC) | ||
Riad Mishlawi | Vesting of LTIP 2011 | 19,067 (0.01% ISC)
| 24 March 2014 | £16.23 | Nil | 79,327 (0.04% ISC) | ||
Khalid Nabilsi | Vesting of LTIP 2011 | 26,011 (0.01% ISC)
| 24 March 2014 | £16.23 | Nil | 196,858 (0.10% ISC) | ||
|
|
| ||||||
Shares in Hikma were trading down 0.1% at 1,625.00 pence Monday midday.
By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews
Copyright © 2014 Alliance News Limited. All Rights Reserved.
Hikma Pharmaceuticals (HIK)